13F Filings History of TAKEDA PHARMACEUTICAL CO LTD

Latest 13F report
Q3 2025 - 13 Nov 2025
Value $
$16,369,175
Signature - Title
Max Heuer - Authorized Signatory
Location
Tokyo, Japan
Summary
This page shows a list of all the recent 13F filings made by TAKEDA PHARMACEUTICAL CO LTD. Form 13F is required to be filed within 45 days of the end of a calendar quarter. TAKEDA PHARMACEUTICAL CO LTD reported 8 stock holdings with total value $16,369,175 as of Q3 2025. Top holdings included OVID, EQ, XLO, STTK, and LYEL.

Notify me when TAKEDA PHARMACEUTICAL CO LTD files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q3 2025 8 $16,369,175 +$222,845 -$13,903,047 -$13,680,202 OVID, EQ, XLO, STTK, LYEL 13F-HR 13 Nov 2025, 07:57
Q2 2025 11 $19,553,783 $0 -$6,914,380 -$6,914,380 HLVX, OVID, XLO, AMWL, EQ 13F-HR 07 Aug 2025, 20:51
Q1 2025 11 $16,194,016 $0 $0 $0 HLVX, OVID, XLO, EQ, AMWL 13F-HR 12 May 2025, 06:19
Q4 2024 11 $26,564,014 +$905,955 -$11,044,514 -$10,138,559 HLVX, OVID, XLO, EQ, STTK 13F-HR 12 Feb 2025, 08:06
Q3 2024 10 $37,950,196 $0 -$128,248,577 -$128,248,577 HLVX, WVE, OVID, STTK, EQ 13F-HR 13 Feb 2025, 06:40
Q2 2024 13 $232,311,238 $0 -$22,533,156 -$22,533,156 DNLI, HLVX, PHAT, WVE, OVID 13F-HR 13 Feb 2025, 06:33
Q1 2024 15 $289,040,735 +$1,418,077 -$51,003,120 -$49,585,043 HLVX, DNLI, PHAT, OVID, STTK 13F-HR 13 Feb 2025, 06:28
Q4 2023 14 $327,499,882 $0 $0 $0 HLVX, DNLI, PHAT, OVID, STTK 13F-HR 13 Feb 2025, 06:13